Natus Medical reported $65.41M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US $ 224.52M 6.13M
Atricure ATRC:US $ 63.52M 7.92M
Boston Scientific BSX:US $ 2222M 163M
Cardiovascular Systems CSII:US $ 46.23M 4.8M
Cooper Companies COO:US $ 552.1M 19.6M
Cryolife CRY:US $ 52.17M 1.45M
Edwards Lifesciences EW:US $ 1104.5M 62.6M
General Electric GE:US $ 5040M 829M
Globus Medical GMED:US $ 195.18M 23.8M
Inogen INGN:US $ 46.26M 11.25M
Insulet PODD:US $ 190.3M 19.4M
Integra Lifesciences IART:US $ 254.54M 15.94M
Koninklijke Philips PHG:US 1.73B 221M
Masimo MASI:US $ 258.2M 53.44M
Medtronic MDT:US $ 4904M 620M
Mesa Laboratories MLAB:US $ 31.34M 3.77M
Natus Medical BABY:US $ 65.41M 7.63M
Perkinelmer PKI:US $ 666.16M 13.07M
Philips PHIA:NA € 1732M 221M
Surmodics SRDX:US $ 19.71M 1.29M
Tandem Diabetes Care TNDM:US $ 101.95M 10.85M
Thermo Fisher Scientific TMO:US $ 4730M 734M
Trinity Biotech TRIB:US $ 7.27M 0.03M